However, the haploinsufficient ubc13+/− mice used here grow normally and are protected against acute inflammation, suggesting that moderate Ubc13 inhibition may be effective in suppression of excessive inflammation or unknown dysfunction induced by aging and obesity. Here, UBE2N is linked to obesity disorder.